Specific EEG resting state biomarkers in FXS and ASD.

Alpha peak frequency Autism spectrum disorder Cognition Fragile X syndrome Multi scale entropy Neurodevelopment Power spectral density Resting state EEG Signal complexity

Journal

Journal of neurodevelopmental disorders
ISSN: 1866-1955
Titre abrégé: J Neurodev Disord
Pays: England
ID NLM: 101483832

Informations de publication

Date de publication:
09 Sep 2024
Historique:
received: 08 01 2024
accepted: 23 08 2024
medline: 10 9 2024
pubmed: 10 9 2024
entrez: 9 9 2024
Statut: epublish

Résumé

Fragile X syndrome (FXS) and autism spectrum disorder (ASD) are neurodevelopmental conditions that often have a substantial impact on daily functioning and quality of life. FXS is the most common cause of inherited intellectual disability (ID) and the most common monogenetic cause of ASD. Previous literature has shown that electrophysiological activity measured by electroencephalogram (EEG) during resting state is perturbated in FXS and ASD. However, whether electrophysiological profiles of participants with FXS and ASD are similar remains unclear. The aim of this study was to compare EEG alterations found in these two clinical populations presenting varying degrees of cognitive and behavioral impairments. Resting state EEG signal complexity, alpha peak frequency (APF) and power spectral density (PSD) were compared between 47 participants with FXS (aged between 5-20), 49 participants with ASD (aged between 6-17), and 52 neurotypical (NT) controls with a similar age distribution using MANCOVAs with age as covariate when appropriate. MANCOVAs controlling for age, when appropriate, and nonverbal intelligence quotient (NVIQ) score were subsequently performed to determine the impact of cognitive functioning on EEG alterations. Our results showed that FXS participants manifested decreased signal complexity and APF compared to ASD participants and NT controls, as well as altered power in the theta, alpha and low gamma frequency bands. ASD participants showed exaggerated beta power compared to FXS participants and NT controls, as well as enhanced low and high gamma power compared to NT controls. However, ASD participants did not manifest altered signal complexity or APF. Furthermore, when controlling for NVIQ, results of decreased complexity in higher scales and lower APF in FXS participants compared to NT controls and ASD participants were not replicated. These findings suggest that signal complexity and APF might reflect cognitive functioning, while altered power in the low gamma frequency band might be associated with neurodevelopmental conditions, particularly FXS and ASD.

Sections du résumé

BACKGROUND BACKGROUND
Fragile X syndrome (FXS) and autism spectrum disorder (ASD) are neurodevelopmental conditions that often have a substantial impact on daily functioning and quality of life. FXS is the most common cause of inherited intellectual disability (ID) and the most common monogenetic cause of ASD. Previous literature has shown that electrophysiological activity measured by electroencephalogram (EEG) during resting state is perturbated in FXS and ASD. However, whether electrophysiological profiles of participants with FXS and ASD are similar remains unclear. The aim of this study was to compare EEG alterations found in these two clinical populations presenting varying degrees of cognitive and behavioral impairments.
METHODS METHODS
Resting state EEG signal complexity, alpha peak frequency (APF) and power spectral density (PSD) were compared between 47 participants with FXS (aged between 5-20), 49 participants with ASD (aged between 6-17), and 52 neurotypical (NT) controls with a similar age distribution using MANCOVAs with age as covariate when appropriate. MANCOVAs controlling for age, when appropriate, and nonverbal intelligence quotient (NVIQ) score were subsequently performed to determine the impact of cognitive functioning on EEG alterations.
RESULTS RESULTS
Our results showed that FXS participants manifested decreased signal complexity and APF compared to ASD participants and NT controls, as well as altered power in the theta, alpha and low gamma frequency bands. ASD participants showed exaggerated beta power compared to FXS participants and NT controls, as well as enhanced low and high gamma power compared to NT controls. However, ASD participants did not manifest altered signal complexity or APF. Furthermore, when controlling for NVIQ, results of decreased complexity in higher scales and lower APF in FXS participants compared to NT controls and ASD participants were not replicated.
CONCLUSIONS CONCLUSIONS
These findings suggest that signal complexity and APF might reflect cognitive functioning, while altered power in the low gamma frequency band might be associated with neurodevelopmental conditions, particularly FXS and ASD.

Identifiants

pubmed: 39251926
doi: 10.1186/s11689-024-09570-9
pii: 10.1186/s11689-024-09570-9
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

53

Informations de copyright

© 2024. Crown.

Références

Centers for Disease Control and Prevention: Data and Statistics on Fragile X Syndrome. 2022. https://www.cdc.gov/ncbddd/fxs/data.html#:~:text=Females%20often%20have%20milder%20symptoms%20than%20males.andtext=The%20exact%20number%20of%20people, have%20been%20diagnosed%20with%20FXS . Accessed 20 Jun 2023.
World Health Organization: Autism. 2023. https://www.who.int/news-room/fact-sheets/detail/autism-spectrum-disorders . Accessed 20 Jun 2023.
Loomes R, Hull L, Mandy WPL. What Is the Male-to-Female Ratio in Autism Spectrum Disorder? A Systematic Review and Meta-Analysis. J Am Acad Child Adolesc Psychiatry. 2017;56(6):466–74. https://doi.org/10.1016/j.jaac.2017.03.013 .
doi: 10.1016/j.jaac.2017.03.013 pubmed: 28545751
Hagerman RJ, Berry-Kravis E, Hazlett H, Bailey DB Jr, Moine H, Kooy RK, et al. Fragile X syndrome. Nat Rev Dis Primers. 2017. https://doi.org/10.1038/nrdp.2017.65 .
Styles M, Alsharshani D, Samara M, Alsharshani M, Khattab A, Qoronfleh MW, Al-Dewik N. Risk factors, diagnosis, prognostic and treatment of autism. Front Biosc. 2020;25:1682–717.
doi: 10.2741/4873
Lee NR, Fidler DJ, Blakeley-Smith A, Daunhauer L, Robinson C, Hepburn SL. Caregiver report of executive functioning in a population-based sample of young children with Down syndrome. Am J Intellect Dev Disabil. 2011;116(4):290–304.
pubmed: 21740257 pmcid: 4512645 doi: 10.1352/1944-7558-116.4.290
Pugin A, Faundes V, Santa María L, Curotto B, Aliaga S, Salas I, et al. Clinical, molecular, and pharmacological aspects of FMR1 -related disorders. Neurología (English Edition). 2017;32(4):241–52.
doi: 10.1016/j.nrleng.2014.10.018
Hernandez RN, Feinberg RL, Vaurio R, Passanante NM, Thompson RE, Kaufmann WE. Autism spectrum disorder in fragile X syndrome: a longitudinal evaluation. Am J Med Genet A. 2009;149A(6):1125–37. https://doi.org/10.1002/ajmg.a.32848 .
doi: 10.1002/ajmg.a.32848 pubmed: 19441123 pmcid: 2734278
Marlborough M, Welham A, Jones C, Reckless S, Moss J. Autism spectrum disorder in females with fragile X syndrome: a systematic review and meta-analysis of prevalence. J Neurodev Disord. 2021;13(1):28. https://doi.org/10.1186/s11689-021-09362-5 .
doi: 10.1186/s11689-021-09362-5 pubmed: 34294028 pmcid: 8299695
Richards C, Jones C, Groves L, Moss J, Oliver C. Prevalence of autism spectrum disorder phenomenology in genetic disorders: a systematic review and meta-analysis. Lancet Psychiatry. 2015;2(10):909–16. https://doi.org/10.1016/S2215-0366(15)00376-4 .
doi: 10.1016/S2215-0366(15)00376-4 pubmed: 26341300
Chonchaiya W, Schneider A, Hagerman RJ. Fragile X: a family of disorders. Adv Pediatr. 2009;56:165–86. https://doi.org/10.1016/j.yapd.2009.08.008 .
doi: 10.1016/j.yapd.2009.08.008 pubmed: 19968948 pmcid: 2921504
Lozano R, Rosero CA, Hagerman RJ. Fragile X spectrum disorders. Intractable Rare Dis Res. 2014;3(4):134–46. https://doi.org/10.5582/irdr.2014.01022 .
doi: 10.5582/irdr.2014.01022 pubmed: 25606363 pmcid: 4298643
Srivastava AK, Schwartz CE. Intellectual disability and autism spectrum disorders: causal genes and molecular mechanisms. Neurosci Biobehav Rev. 2014;46(Pt 2):161–74. https://doi.org/10.1016/j.neubiorev.2014.02.015 .
doi: 10.1016/j.neubiorev.2014.02.015 pubmed: 24709068
Hagerman R, Lauterborn J, Au J, Berry-Kravis E. Fragile X syndrome and targeted treatment trials. Results Probl Cell Differ. 2012;54:297–335.
pubmed: 22009360 pmcid: 4114775 doi: 10.1007/978-3-642-21649-7_17
Rubenstein JL, Merzenich MM. Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav. 2003;2:255–67. https://doi.org/10.1034/j.1601-183x.2003.00037.x .
doi: 10.1034/j.1601-183x.2003.00037.x pubmed: 14606691
Bear MF, Huber KM, Warren ST. The mGluR theory of fragile X mental retardation. Trends Neurosci. 2004;27(7):370–7.
pubmed: 15219735 doi: 10.1016/j.tins.2004.04.009
Bassell GJ, Warren ST. Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron. 2008;60(2):201–14.
pubmed: 18957214 pmcid: 3691995 doi: 10.1016/j.neuron.2008.10.004
Devitt NM, Gallagher L, Reilly RB. Autism Spectrum Disorder (ASD) and Fragile X Syndrome (FXS): Two Overlapping Disorders Reviewed through Electroencephalography-What Can be Interpreted from the Available Information? Brain Sci. 2015;5(2):92–117.
pubmed: 25826237 doi: 10.3390/brainsci5020092
Neuhaus E, Lowry SJ, Santhosh M, Kresse A, Edwards LA, Keller J, et al. Resting state EEG in youth with ASD: age, sex, and relation to phenotype. J Neurodev Disord. 2021;13(1):33.
pubmed: 34517813 pmcid: 8439051 doi: 10.1186/s11689-021-09390-1
Proteau-Lemieux M, Knoth IS, Agbogba K, Cote V, Barlahan Biag HM, Thurman AJ, et al. EEG Signal Complexity Is Reduced During Resting-State in Fragile X Syndrome. Front Psychiatry. 2021;12(716707):1–16.
Wang J, Ethridge LE, Mosconi MW, White SP, Binder DK, Pedapati EV, et al. A resting EEG study of neocortical hyperexcitability and altered functional connectivity in fragile X syndrome. J Neurodev Disord. 2017;9(11):1–12.
van Diessen E, Senders J, Jansen FE, Boersma M, Bruining H. Increased power of resting-state gamma oscillations in autism spectrum disorder detected by routine electroencephalography. Eur Arch Psychiatry Clin Neurosci. 2015;265(6):537–40.
pubmed: 25182536 doi: 10.1007/s00406-014-0527-3
Zhao J, Song J, Li X, Kang J. A study on EEG feature extraction and classification in autistic children based on singular spectrum analysis method. Brain Behav. 2020;10(12): e01721.
pubmed: 33125837 pmcid: 7749618 doi: 10.1002/brb3.1721
Bosl W, Tierney A, Tager-Flusberg H, Nelson C. EEG complexity as a biomarker for autism spectrum disorder risk. BMC Med. 2011;9:18.
pubmed: 21342500 pmcid: 3050760 doi: 10.1186/1741-7015-9-18
Liu T, Chen Y, Chen D, Li C, Qiu Y, Wang J. Altered electroencephalogram complexity in autistic children shown by the multiscale entropy approach. NeuroReport. 2017;28(3):169–73.
pubmed: 27984543 pmcid: 5287424 doi: 10.1097/WNR.0000000000000724
Clarke AR, Barry RJ, Johnstone SJ, McCarthy R, Selikowitz M. EEG development in Attention Deficit Hyperactivity Disorder: From child to adult. Clin Neurophysiol. 2019;130(8):1256–62.
pubmed: 31163371 doi: 10.1016/j.clinph.2019.05.001
Dickinson A, DiStefano C, Senturk D, Jeste SS. Peak alpha frequency is a neural marker of cognitive function across the autism spectrum. Eur J Neurosci. 2018;47(6):643–51.
pubmed: 28700096 doi: 10.1111/ejn.13645
Heisz JJ, Shedden JM, McIntosh AR. Relating brain signal variability to knowledge representation. Neuroimage. 2012;63(3):1384–92.
pubmed: 22906786 doi: 10.1016/j.neuroimage.2012.08.018
Lippe S, Kovacevic N, McIntosh AR. Differential maturation of brain signal complexity in the human auditory and visual system. Front Hum Neurosci. 2009;3(48):1–9.
Roid GHML, Pomplun M, Koch C. Leiter International Performance Scale. 3rd ed. Wood Dale, IL: Stoelting Co; 2013.
Roid GH. Standford-Binet Intelligence Scales. 5th ed. Itasca, IL: Riverside Publishing; 2003.
Wechsler D. Wechsler Abbreviated Scale of Intelligence. 2nd ed. Bloomington: MN Psychological Corp; 2011.
Sansone SM, Widaman KF, Hall SS, Reiss AL, Lightbody A, Kaufmann WE, et al. Psychometric study of the aberrant behavior checklist in fragile X syndrome and implications for targeted treatment. J Autism Dev Disord. 2012;42(7):1377–92.
pubmed: 21972117 pmcid: 3290710 doi: 10.1007/s10803-011-1370-2
Chatham CH, Taylor KI, Charman T, Liogier D’ardhuy X, Eule E, Fedele A, et al. Adaptive behavior in autism: Minimal clinically important differences on the Vineland-II. Autism Res. 2018;11(2):270–83.
pubmed: 28941213 doi: 10.1002/aur.1874
Davoudi S, Parto Dezfouli M, Knight RT, Daliri MR, Johnson EL. Prefrontal Lesions Disrupt Posterior Alpha-Gamma Coordination of Visual Working Memory Representations. J Cogn Neurosci. 2021;33(9):1798–810.
pubmed: 34375418 pmcid: 8428813 doi: 10.1162/jocn_a_01715
Costa M, Goldberger AL, Peng CK. Multiscale entropy analysis of biological signals. Phys Rev E Stat Nonlin Soft Matter Phys. 2005. https://doi.org/10.1103/PhysRevE.71.021906 .
doi: 10.1103/PhysRevE.71.021906 pubmed: 16090134
Saby JN, Marshall PJ. The utility of EEG band power analysis in the study of infancy and early childhood. Dev Neuropsychol. 2012;37(3):253–73.
pubmed: 22545661 pmcid: 3347767 doi: 10.1080/87565641.2011.614663
Blakesley RE, Mazumdar S, Dew MA, Houck PR, Tang G, Reynolds CF 3rd, et al. Comparisons of methods for multiple hypothesis testing in neuropsychological research. Neuropsychology. 2009;23(2):255–64.
pubmed: 19254098 pmcid: 3045855 doi: 10.1037/a0012850
Catarino A, Churches O, Baron-Cohen S, Andrade A, Ring H. Atypical EEG complexity in autism spectrum conditions: a multiscale entropy analysis. Clin Neurophysiol. 2011;122(12):2375–83.
pubmed: 21641861 doi: 10.1016/j.clinph.2011.05.004
Takahashi T, Yoshimura Y, Hiraishi H, Hasegawa C, Munesue T, Higashida H, et al. Enhanced brain signal variability in children with autism spectrum disorder during early childhood. Hum Brain Mapp. 2016;37(3):1038–50.
pubmed: 26859309 doi: 10.1002/hbm.23089
Ghanbari Y, Bloy L, Christopher Edgar J, Blaskey L, Verma R, Roberts TP. Joint analysis of band-specific functional connectivity and signal complexity in autism. J Autism Dev Disord. 2015;45(2):444–60.
pubmed: 23963593 pmcid: 3931749 doi: 10.1007/s10803-013-1915-7
Hadoush H, Alafeef M, Abdulhay E. Brain Complexity in Children with Mild and Severe Autism Spectrum Disorders: Analysis of Multiscale Entropy in EEG. Brain Topogr. 2019;32(5):914–21.
pubmed: 31006838 doi: 10.1007/s10548-019-00711-1
Angulo-Ruiz BY, Munoz V, Rodriguez-Martinez EI, Cabello-Navarro C, Gomez CM. Multiscale entropy of ADHD children during resting state condition. Cogn Neurodyn. 2023;17(4):869-91.
pubmed: 37522046 doi: 10.1007/s11571-022-09869-0
Freschl J, Azizi LA, Balboa L, Kaldy Z, Blaser E. The development of peak alpha frequency from infancy to adolescence and its role in visual temporal processing: A meta-analysis. Dev Cogn Neurosci. 2022;57: 101146.
pubmed: 35973361 pmcid: 9399966 doi: 10.1016/j.dcn.2022.101146
Smith EG, Pedapati EV, Liu R, Schmitt LM, Dominick KC, Shaffer RC, et al. Sex differences in resting EEG power in Fragile X Syndrome. J Psychiatr Res. 2021;138:89–95.
pubmed: 33836434 pmcid: 8192450 doi: 10.1016/j.jpsychires.2021.03.057
Wang J, Barstein J, Ethridge LE, Mosconi MW, Takarae Y, Sweeney JA. Resting state EEG abnormalities in autism spectrum disorders. J Neurodev Disorders. 2013;5(24):1–14.
Shephard E, Tye C, Ashwood KL, Azadi B, Asherson P, Bolton PF, et al. Resting-State Neurophysiological Activity Patterns in Young People with ASD, ADHD, and ASD + ADHD. J Autism Dev Disord. 2018;48(1):110–22.
pubmed: 28900800 doi: 10.1007/s10803-017-3300-4
Coben R, Clarke AR, Hudspeth W, Barry RJ. EEG power and coherence in autistic spectrum disorder. Clin Neurophysiol. 2008;119(5):1002–9.
pubmed: 18331812 doi: 10.1016/j.clinph.2008.01.013
Chan AS, Sze SL, Cheung MC. Quantitative electroencephalographic profiles for children with autistic spectrum disorder. Neuropsychology. 2007;21(1):74–81.
pubmed: 17201531 doi: 10.1037/0894-4105.21.1.74
Dawson G, Grofer Klinger L, Panagiotides H, Lewy A, Castelloe P. Subgroups of autistic children based on social behavior display distinct patterns of brain activity. J Abnorm Child Psychol. 1995;23(5):569–83.
pubmed: 8568080 doi: 10.1007/BF01447662
Van der Molen MJ, Van der Molen MW. Reduced alpha and exaggerated theta power during the resting-state EEG in fragile X syndrome. Biol Psychol. 2013;92(2):216–9.
pubmed: 23182872 doi: 10.1016/j.biopsycho.2012.11.013
Cantor DS, Thatcher RW, Hrybyk M, Kaye H. Computerized EEG analyses of autistic children. J Autism Dev Disord. 1986;16(2):169–87.
pubmed: 3722118 doi: 10.1007/BF01531728
Cornew L, Roberts TP, Blaskey L, Edgar JC. Resting-state oscillatory activity in autism spectrum disorders. J Autism Dev Disord. 2012;42(9):1884–94.
pubmed: 22207057 pmcid: 3638261 doi: 10.1007/s10803-011-1431-6
Sutton SK, Burnette CP, Mundy PC, Meyer J, Vaughan A, Sanders C, et al. Resting cortical brain activity and social behavior in higher functioning children with autism. J Child Psychol Psychiatry. 2005;46(2):211–22.
pubmed: 15679529 doi: 10.1111/j.1469-7610.2004.00341.x
Bink M, van Boxtel GJ, Popma A, Bongers IL, Denissen AJ, van Nieuwenhuizen C. EEG theta and beta power spectra in adolescents with ADHD versus adolescents with ASD + ADHD. Eur Child Adolesc Psychiatry. 2015;24(8):873–86.
pubmed: 25374034 doi: 10.1007/s00787-014-0632-x
Angulo-Ruiz BY, Ruiz-Martinez FJ, Rodriguez-Martinez EI, Ionescu A, Saldana D, Gomez CM. Linear and Non-linear Analyses of EEG in a Group of ASD Children During Resting State Condition. Brain Topogr. 2023;36(5):736-49.
pubmed: 37330940 pmcid: 10415465 doi: 10.1007/s10548-023-00976-7
Orekhova EV, Stroganova TA, Nygren G, Tsetlin MM, Posikera IN, Gillberg C, et al. Excess of high frequency electroencephalogram oscillations in boys with autism. Biol Psychiatry. 2007;62(9):1022–9.
pubmed: 17543897 doi: 10.1016/j.biopsych.2006.12.029
Carreno-Munoz MI, Chattopadhyaya B, Agbogba K, Cote V, Wang S, Levesque M, et al. Sensory processing dysregulations as reliable translational biomarkers in SYNGAP1 haploinsufficiency. Brain. 2022;145(2):754–69.
pubmed: 34791091 doi: 10.1093/brain/awab329
Cote V, Knoth IS, Agbogba K, Vannasing P, Cote L, Major P, et al. Differential auditory brain response abnormalities in two intellectual disability conditions: SYNGAP1 mutations and Down syndrome. Clin Neurophysiol. 2021;132(8):1802–12.
pubmed: 34130248 doi: 10.1016/j.clinph.2021.03.054
Campbell IG, Feinberg I. Longitudinal trajectories of non-rapid eye movement delta and theta EEG as indicators of adolescent brain maturation. PNAS. 2009;106(13):5177–80.
pubmed: 19307577 pmcid: 2664015 doi: 10.1073/pnas.0812947106
Cragg L, Kovacevic N, McIntosh AR, Poulsen C, Martinu K, Leonard G, et al. Maturation of EEG power spectra in early adolescence: a longitudinal study. Dev Sci. 2011;14(5):935–43.
pubmed: 21884309 doi: 10.1111/j.1467-7687.2010.01031.x
Cea-Del Rio CA, Huntsman MM. The contribution of inhibitory interneurons to circuit dysfunction in Fragile X Syndrome. Front Cell Neurosci. 2014;8(245):1–7.
Klimesch W, Sauseng P, Hanslmayr S. EEG alpha oscillations: the inhibition-timing hypothesis. Brain Res Rev. 2007;53(1):63–88.
pubmed: 16887192 doi: 10.1016/j.brainresrev.2006.06.003

Auteurs

Mélodie Proteau-Lemieux (M)

Department of Psychology, University of Montreal, Montreal, QC, Canada.
Research Center of the Sainte-Justine University Hospital, Montreal, QC, Canada.

Inga Sophia Knoth (IS)

Research Center of the Sainte-Justine University Hospital, Montreal, QC, Canada.

Saeideh Davoudi (S)

Research Center of the Sainte-Justine University Hospital, Montreal, QC, Canada.
Department of Neuroscience, University of Montreal, Montreal, QC, Canada.

Charles-Olivier Martin (CO)

Research Center of the Sainte-Justine University Hospital, Montreal, QC, Canada.

Anne-Marie Bélanger (AM)

Research Center of the Sainte-Justine University Hospital, Montreal, QC, Canada.

Valérie Fontaine (V)

Research Center of the Sainte-Justine University Hospital, Montreal, QC, Canada.

Valérie Côté (V)

Research Center of the Sainte-Justine University Hospital, Montreal, QC, Canada.

Kristian Agbogba (K)

Research Center of the Sainte-Justine University Hospital, Montreal, QC, Canada.

Keely Vachon (K)

University of Alberta, Edmonton, AB, Canada.

Kerri Whitlock (K)

University of Alberta, Edmonton, AB, Canada.

Hazel Maridith Barlahan Biag (HMB)

Department of Pediatrics and MIND Institute, University of California Davis School of Medicine, Sacramento, CA, USA.

Angela John Thurman (AJ)

Department of Psychiatry and Behavioral Sciences and MIND Institute, University of California Davis School of Medicine, Sacramento, CA, USA.

Cory Rosenfelt (C)

Department of Pediatric Neurology, University of Alberta, Edmonton, AB, Canada.

Flora Tassone (F)

Department of Biochemistry and Molecular Medicine, University of California Davis School of Medicine, Sacramento, CA, USA.

Julia Frei (J)

McMaster University of Ottawa, Ottawa, ON, Canada.

Lucia Capano (L)

Queen's University of Kingston, Kingston, ON, Canada.

Leonard Abbeduto (L)

Department of Psychiatry and Behavioral Sciences and MIND Institute, University of California Davis School of Medicine, Sacramento, CA, USA.

Sébastien Jacquemont (S)

Research Center of the Sainte-Justine University Hospital, Montreal, QC, Canada.
Department of Pediatrics, University of Montreal, Montreal, QC, Canada.

David Hessl (D)

Department of Psychiatry and Behavioral Sciences and MIND Institute, University of California Davis School of Medicine, Sacramento, CA, USA.

Randi Jenssen Hagerman (RJ)

Department of Pediatrics and MIND Institute, University of California Davis School of Medicine, Sacramento, CA, USA.

Andrea Schneider (A)

Department of Pediatrics and MIND Institute, University of California Davis School of Medicine, Sacramento, CA, USA.

Francois Bolduc (F)

Department of Pediatrics, University of Alberta, Edmonton, AB, Canada.

Evdokia Anagnostou (E)

Department of Paediatrics, University of Toronto, Toronto, ON, Canada.
Holland Bloorview Research Center, Toronto, ON, Canada.

Sarah Lippe (S)

Department of Psychology, University of Montreal, Montreal, QC, Canada. Sarah.lippe@umontreal.ca.
Research Center of the Sainte-Justine University Hospital, Montreal, QC, Canada. Sarah.lippe@umontreal.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH